CommentPreserving brain health after intracerebral haemorrhage
References (9)
- et al.
Apixaban versus no anticoagulation after anticoagulationassociated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
Lancet Neurol
(2021) - et al.
Intracerebral hemorrhage: an update on diagnosis and treatment
Expert Rev Neurother
(2019) - et al.
Five-year risk of major ischemic and hemorrhagic events after intracerebral hemorrhage
Stroke
(2019) - et al.
Association of cerebral small vessel disease and cognitive decline after intracerebral hemorrhage
Neurology
(2021)
There are more references available in the full text version of this article.
Cited by (4)
More severe initial manifestations and worse short-term functional outcome of intracerebral hemorrhage in the plateau than in the plain
2024, Journal of Cerebral Blood Flow and MetabolismThe Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases
2023, Molecular NeurobiologyThe hallmark and crosstalk of immune cells after intracerebral hemorrhage: Immunotherapy perspectives
2023, Frontiers in Neuroscience
© 2021 Elsevier Ltd. All rights reserved.